VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,000 | -35.9% | 20,000 | 0.0% | 0.02% | -31.4% |
| Q4 2021 | $39,000 | -29.1% | 20,000 | 0.0% | 0.04% | -37.5% |
| Q3 2021 | $55,000 | -12.7% | 20,000 | 0.0% | 0.06% | -13.8% |
| Q2 2021 | $63,000 | +46.5% | 20,000 | 0.0% | 0.06% | +35.4% |
| Q1 2021 | $43,000 | +10.3% | 20,000 | 0.0% | 0.05% | 0.0% |
| Q4 2020 | $39,000 | +178.6% | 20,000 | 0.0% | 0.05% | +140.0% |
| Q3 2020 | $14,000 | +27.3% | 20,000 | 0.0% | 0.02% | +25.0% |
| Q2 2020 | $11,000 | +22.2% | 20,000 | 0.0% | 0.02% | +6.7% |
| Q1 2020 | $9,000 | -35.7% | 20,000 | 0.0% | 0.02% | -16.7% |
| Q4 2019 | $14,000 | -33.3% | 20,000 | 0.0% | 0.02% | -37.9% |
| Q3 2019 | $21,000 | +40.0% | 20,000 | 0.0% | 0.03% | +61.1% |
| Q2 2019 | $15,000 | -42.3% | 20,000 | 0.0% | 0.02% | -18.2% |
| Q1 2019 | $26,000 | -13.3% | 20,000 | 0.0% | 0.02% | -18.5% |
| Q4 2018 | $30,000 | +3.4% | 20,000 | 0.0% | 0.03% | +17.4% |
| Q3 2018 | $29,000 | +7.4% | 20,000 | 0.0% | 0.02% | +4.5% |
| Q2 2018 | $27,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|